DRUG · Bright Minds Biosciences Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 21.55 USD |
|---|---|
| 1-day change | -17.8% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 3 / 4 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 5 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -12.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.5% |
| Market cap (USD) | $867.9M |